Left Atrial Appendage (LAA) Occluders

This channel includes news and new technology innovations about Left Atrial Appendage (LAA) Occluders. These close off the LAA in patients with atrial fibrillation to prevent the formation of stroke-causing clots in atrial fibrillation (AFib or AF) patients. LAA occlusion is often indicated for patients who do not tolerate anticoagulation therpy or have bleeding risks associated with use of that therapy.

Boston Scientific, investors, cardiology, growth, expansion
News | May 11, 2015
May 11, 2015 — Boston Scientific Corp. presented an overview of its continued business momentum and long-term growth...
Watchman, LAA, left atrial appendage

The Watchman LAA occluder being implanted in the left atrial appendage via a delivery catheter through a transseptal puncture.

Feature | Left Atrial Appendage (LAA) Occluders | April 30, 2015 | Dave Fornell
The long-awaited U.S. Food and Drug Administration (FDA) approval of the first transcatheter left atrial appendage (LAA...
Watchman, Mount Sinai, first, eastern United States, implant
News | March 25, 2015
March 25, 2015 — Mount Sinai experts were the first in the eastern United States on March 23 to implant the Watchman...
Videos | ACC | March 25, 2015
DAIC Editor Dave Fornell shares his picks of the most interesting new devices and advances in cardiovascular technology...
cryoICE, Atricure, ablation probe, cryoanalgesia, thoracotomy

CRYO2 image courtesy of AtriCure Inc.

Technology | March 23, 2015
March 23, 2015 — AtriCure Inc. announced that it has launched the availability of its cryoICE cryo ablation probe (...
News | March 13, 2015
March 13, 2015 — AtriCure Inc. announced the first two patients in the Dual Epicardial and Endocardial Procedure (DEEP...
News | February 10, 2015 | Dave Fornell
As editor of DAIC, I keep a close watch on trends in cardiovascular technology and try to predict what the next big...
News | October 13, 2014
October 13, 2014 — After reviewing updated data and analysis for the Boston Scientific Watchman left atrial appendage (...
AtriCure AtriClip Flex Atrial Fibrillation Therapies Cardiac Surgery LAA Occlude
Technology | September 26, 2014
September 26, 2014 — AtriCure Inc. announced the introduction of the AtriClip Flex, a new device with a more flexible...
News | July 22, 2014
July 22, 2014 — AtriCure announced it has sold more than 34,000 AtriClip left atrial appendage (LAA) exclusion system...
atrial fibrillation, LARIAT
Feature | March 24, 2014
March 24, 2014 – Doctors at the Stony Brook Heart Institute Electrophysiology Lab are using a new nonsurgical technique...
Watchman, LAA occluder, atrial fibrillation
Feature | December 12, 2013
December 12, 2013 — The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices...
laa occluders structural heart atrial fibrillation atricure atriclip exclusion
Feature | November 19, 2013
November 19, 2013 — AtriCure Inc., a developer of solutions to treat atrial fibrillation, announced the U.S. Food and...
catheters cath lab ep laa occluders baylis medical torflex transseptal sheath
News | November 11, 2013
November 11, 2013 — The U.S. Food and Drug Administration (FDA) announced a Class I recall of Baylis Medical’s TorFlex...
Blog | November 08, 2013
By Dave Fornell, DAIC editor The Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics (TCT)...